Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study
Authors:
- Jeffrey L. BennettJBJeffrey L. Bennett
- Kazuo FujiharaKFKazuo Fujihara
- Albert SaizASAlbert Saiz
- Anthony L. TraboulseeATAnthony L. Traboulsee
- Benjamin M. GreenbergBGBenjamin M. Greenberg
- Brian G. WeinshenkerBWBrian G. Weinshenker
- Francesco PattiFPFrancesco Patti
- Ingo KleiterIKIngo Kleiter
- Jacqueline PalaceJPJacqueline Palace
- Jerome De SezeJSJerome De Seze
- Rachael EvansRERachael Evans
- Kathleen BlondeauKBKathleen Blondeau
- 1 November 2025
- journal article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (6) , e200494